📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Lenskart Seeks Shareholder Approval for ESOP 2021 and 2025 Plan Amendments
Lenskart Solutions Limited has issued a postal ballot notice to seek shareholder approval for four special resolutions concerning its Employee Stock Option Plans (ESOP). The company intends to amend and ratify the ESOP 2021 and ESOP 2025 schemes to ensure full compliance with SEBI (Share Based Employee Benefit and Sweat Equity) Regulations, 2021. Furthermore, the resolutions propose extending these grants to eligible employees of subsidiary and associate companies globally. This administrative step follows the company's listing and is aimed at aligning incentive structures with regulatory requirements for public companies.
Key Highlights
Proposed ratification of ESOP Plan 2021 and ESOP Plan 2025 to align with SEBI SBEB Regulations.
Extension of stock option eligibility to employees of group, subsidiary, and associate companies in India and abroad.
Remote e-voting period is set from February 19, 2026, to March 20, 2026, with results by March 23, 2026.
The resolutions are classified as Special Resolutions, requiring a 75% majority for approval.
Equity shares underlying the options have a face value of Rs. 2 per share.
💼 Action for Investors
Investors should note that these amendments are standard post-IPO compliance measures to manage employee compensation and retention. While ESOPs lead to minor equity dilution, they are essential for talent management in high-growth retail-tech firms.
Lenskart Q3 FY26: PAT Triples to ₹1,327M, Revenue Up 37.4% with 20% EBITDA Margin
Lenskart reported a robust Q3 FY26 with revenue growing 37.4% YoY, driven by strong volume expansion and new customer additions. Profitability saw a massive jump as EBITDA grew 90.6% YoY, with margins expanding from 14.5% to 20.0% due to structural operating leverage. Net profit (PAT) tripled to ₹1,327 million for the quarter, while the company added 195 net new stores globally. The international segment is scaling rapidly, achieving a 6.1% EBITDA margin (pre-IndAS 116) in 9M FY26, significantly outpacing India's historical profitability curve at a similar scale.
Key Highlights
Revenue grew 37.4% YoY in Q3 FY26, with India growing 40.4% and International 32.7%.
EBITDA margins expanded to 20.0% from 14.5% YoY, resulting in a 1.9x growth in EBITDA.
PAT for Q3 FY26 reached ₹1,327 million, a 3.4x increase compared to ₹393 million in Q3 FY25.
India delivered record Same-Store Sales Growth (SSSG) of 27.8% and Same Pincode Sales Growth (SPSG) of 35.8%.
Conducted 6.3 million eye tests in Q3 (+54% YoY), with 49% being first-time exams, effectively expanding the addressable market.
💼 Action for Investors
Investors should monitor the company's successful 'House of Brands' strategy and its ability to maintain high SSSG despite aggressive store densification. The rapid margin expansion in international markets like Japan and Singapore suggests a scalable and increasingly profitable global model.
Lenskart Approves ESOP Plans for 3.33 Crore Shares and Subsidiary Loan-to-Equity Conversion
Lenskart's board has ratified the 2021 ESOP plan involving 2.6 crore options and approved a new 2025 ESOP plan for 72.8 lakh options. The 2025 plan will primarily utilize secondary market acquisitions via a trust route, which helps limit fresh equity dilution for existing shareholders. Additionally, the company is converting existing inter-company loans into equity for its key overseas subsidiaries, Lenskart Singapore and NESO Brands. These measures are designed to align global employee interests and strengthen the balance sheets of international units.
Key Highlights
Ratified ESOP Plan 2021 covering 2,60,40,528 options through fresh allotment (Direct Route)
Approved ESOP Plan 2025 for 7,280,431 options with secondary market acquisition as the primary mode
Exercise price for both plans set at 30-day average closing price with a maximum 25% discount
Authorized conversion of pre-existing inter-company loans to equity in Lenskart Singapore Pte. Ltd. and NESO Brands Pte. Ltd.
ESOP benefits extended to employees of all group companies, subsidiaries, and associates globally
💼 Action for Investors
Investors should view the secondary acquisition route for the 2025 ESOP plan as a positive step to prevent dilution, while monitoring the performance of overseas subsidiaries following the capital restructuring.
Lenskart Board Approves ESOP Plans for 33M+ Shares and Subsidiary Loan-to-Equity Conversion
Lenskart Solutions Limited has ratified two major Employee Stock Option Plans, ESOP 2021 and ESOP 2025, covering a total of 33,320,959 options. ESOP 2021 involves the fresh allotment of 26,040,528 shares, while ESOP 2025 covers 7,280,431 shares primarily through secondary market acquisition via a Trust route. Furthermore, the board approved converting existing inter-company loans into equity for its overseas subsidiaries, Lenskart Singapore Pte. Ltd. and NESO Brands Pte. Ltd. These measures are designed to enhance talent retention across global operations and optimize the capital structure of international units.
Key Highlights
Ratified ESOP Plan 2021 involving 26,040,528 options of face value Rs. 2 each through direct fresh allotment.
Approved ESOP Plan 2025 for 7,280,431 options with secondary market acquisition as the primary mode via a Trust.
Exercise price for options set at 30-day average closing price with a maximum allowable discount of 25%.
Authorized conversion of pre-existing inter-company loans to equity in Lenskart Singapore Pte. Ltd. and NESO Brands Pte. Ltd.
ESOP benefits extended to employees of all group companies, subsidiaries, and associates in India and abroad.
💼 Action for Investors
Investors should note the potential equity dilution from the 26 million shares under ESOP 2021, while the loan conversion indicates a strengthening of the balance sheets for key overseas subsidiaries.
Lenskart Approves ESOP Plans for 3.33 Crore Shares and Subsidiary Loan-to-Equity Conversion
Lenskart Solutions Limited has ratified two major Employee Stock Option Plans, ESOP 2021 and ESOP 2025, covering a total of approximately 3.33 crore equity shares. ESOP 2021 involves 2.60 crore options via fresh allotment, while ESOP 2025 involves 72.8 lakh options primarily through secondary market acquisition to minimize dilution. The board also approved converting existing inter-company loans into equity for its overseas subsidiaries, Lenskart Singapore Pte. Ltd. and NESO Brands Pte. Ltd. These moves aim to strengthen talent retention across global operations and optimize the capital structure of international units.
Key Highlights
Ratification of ESOP 2021 covering 2,60,40,528 options via direct fresh allotment of shares
Approval of ESOP 2025 for 7,280,431 options with secondary market acquisition as the primary implementation mode
Exercise price for both plans set at 30-day average closing price with a maximum permissible discount of 25%
Conversion of pre-existing inter-company loans to equity in wholly owned subsidiaries Lenskart Singapore and NESO Brands
Extension of ESOP benefits to employees of all group companies, subsidiaries, and associates globally
💼 Action for Investors
Investors should note the potential equity dilution from ESOP 2021 fresh allotments, though the use of secondary acquisitions for ESOP 2025 mitigates this risk. The loan-to-equity conversion in Singapore subsidiaries indicates a long-term commitment to strengthening international balance sheets.
Lenskart Q3 FY26 Revenue Surges 38% YoY to ₹23,077 Million; Growth Momentum Continues
Lenskart Solutions Limited reported a robust performance for the quarter ended December 31, 2025, with revenue from operations reaching ₹23,077.31 million, a 38.3% increase from ₹16,688.35 million in the same quarter last year. For the nine-month period, revenue stood at ₹62,983.31 million, up from ₹49,249.48 million in the previous year. While employee benefit expenses rose significantly to ₹5,277.87 million, the company maintained a positive gap between total income (₹23,480.95 million) and total expenses (₹21,626.41 million). The results reflect the successful integration of recent global acquisitions and expansion across its 23 subsidiaries.
Key Highlights
Quarterly revenue from operations grew 38.3% YoY to ₹23,077.31 million.
Nine-month revenue for FY26 reached ₹62,983.31 million, showing strong 27.9% growth over 9M FY25.
Employee benefit expenses increased to ₹5,277.87 million from ₹3,251.06 million YoY, indicating aggressive hiring and scale.
Total income for Q3 FY26 stood at ₹23,480.95 million against total expenses of ₹21,626.41 million.
Consolidated results now include impact from new acquisitions like Stellio Ventures and Quantduo Technologies.
💼 Action for Investors
Investors should view the strong revenue growth as a sign of successful market penetration and scale. Monitor the rising employee and operational costs to ensure that margins are not compromised during this high-growth phase.
Lenskart Expands Global Reach with New UK Subsidiary for 'Meller' Brand
Lenskart Solutions Limited has incorporated a new step-down subsidiary, Stellio Ventures UK LTD, in England and Wales effective January 5, 2026. The company will indirectly hold an 84.21% stake in this new entity through its subsidiary Stellio Ventures, S.L. The UK unit is established to drive the retail sale of 'Meller' brand eyewear and accessories in the United Kingdom. This strategic move marks a formal entry into the UK market, leveraging an existing brand within the group's portfolio.
Key Highlights
Incorporation of Stellio Ventures UK LTD completed on January 5, 2026
Lenskart holds an 84.21% indirect controlling interest in the new step-down subsidiary
Initial paid-up capital of the UK entity is GBP 100, comprising 100 ordinary shares
The subsidiary is dedicated to the sale of 'Meller' brand eyewear products in the UK market
💼 Action for Investors
Monitor the operational rollout and sales performance of the 'Meller' brand in the UK to gauge the success of Lenskart's international expansion strategy.
Lenskart Expands to UK with New Step-Down Subsidiary Stellio Ventures UK LTD
Lenskart Solutions Limited has announced the incorporation of a new step-down subsidiary, Stellio Ventures UK LTD, in the United Kingdom. The entity is being established through Lenskart's subsidiary, Stellio Ventures, S.L., to operate retail stores for the 'Meller' eyewear brand. Lenskart will indirectly hold an 84.21% stake in the new UK-based entity. While the initial subscription cost is a nominal GBP 100, this move marks a strategic push into the European retail market.
Key Highlights
Incorporation of Stellio Ventures UK LTD as a step-down subsidiary in the United Kingdom
Lenskart to maintain an 84.21% indirect shareholding in the new entity
Objective is to establish retail stores for the 'Meller' brand eyewear and accessories
Initial investment for share subscription is GBP 100 with further funding to be approved by the board
💼 Action for Investors
Investors should view this as a positive step toward international diversification and monitor the brand's performance in the UK retail market. The success of the 'Meller' brand rollout will be a key metric for Lenskart's global growth strategy.
Lenskart to Acquire 29.24% Stake in South Korean Tech Startup iiNeer for INR 186 Million
Lenskart Solutions, through its Singapore subsidiary, is investing KRW 3 billion (approximately INR 186 million) to acquire a 29.24% stake in South Korea-based iiNeer Corp., Ltd. iiNeer specializes in optical machinery, specifically technology-enabled eye-testing and lens-cutting equipment. This strategic move is designed to build in-house hardware capabilities, which Lenskart expects will improve operating efficiencies and reduce future capital expenditure on equipment. The transaction is structured as a cash deal for 123,945 preference shares and is expected to close by January 31, 2026.
Key Highlights
Acquisition of 29.24% stake in iiNeer Corp., Ltd. for KRW 3 billion (~INR 186 million)
Target company focuses on manufacturing lens-edging systems, including edgers, tracers, and blockers
Strategic goal to build proprietary optical hardware and reduce long-term equipment CapEx
iiNeer reported a turnover of KRW 177,768,000 for the calendar year 2024
Transaction expected to be completed by January 31, 2026, via cash consideration
💼 Action for Investors
Investors should view this as a positive step toward vertical integration and cost optimization. Monitor the successful integration of this technology into Lenskart's supply chain to see if it leads to improved margins.
Lenskart to Acquire 50% Stake in Thailand's Marco Optical for USD 5 Million
Lenskart Solutions Limited, through its Singapore-based subsidiary, has approved the acquisition of a 50% stake in Marco Optical (Thailand) Co., Ltd. for a total investment of USD 5 million (approximately THB 168.75 million). The target company, which specializes in eyewear manufacturing and trading, will operate as a 50:50 joint venture with Matt Optical. This strategic move is aimed at strengthening Lenskart's manufacturing and supply chain capabilities in the Southeast Asian market. The investment includes a purchase of 250,000 shares and a loan component that may be converted into equity in the future.
Key Highlights
Acquisition of 250,000 ordinary shares representing 50% of Marco Optical (Thailand) Co., Ltd.
Total investment commitment of USD 5,000,000 (approx. THB 168.75 million).
Target company turnover grew from THB 3,985.96 in 2023 to THB 101,624.28 in 2024.
Strategic focus on manufacturing, wholesale, and export of eye frames, lenses, and sunglasses.
The entity will function as a 50:50 Joint Venture between Lenskart Singapore and Matt Optical.
💼 Action for Investors
This acquisition marks a significant step in Lenskart's vertical integration and regional expansion strategy. Investors should monitor the scaling of this manufacturing unit as it could lead to improved margins and better supply chain control.
Lenskart Q2 FY26 PAT Jumps 50% to ₹113 Cr; Revenue Up 24% with Strong Margin Expansion
Lenskart reported a robust performance for Q2 FY26 with pro forma revenue reaching INR 21,466 million, a 24% YoY increase. Profitability saw a significant boost as PAT surged 50% to INR 1,130 million, while EBITDA margins expanded to 19.8% driven by vertical integration and operating leverage. The company's India business remains the primary driver with 24.7% H1 growth, supported by 203 net new store additions and a 52% increase in eye tests. Management highlighted that H1 FY26 PAT has already nearly matched the adjusted PAT for the entire previous fiscal year.
Key Highlights
Q2 FY26 pro forma revenue grew 24% YoY to INR 21,466 million with EBITDA margins expanding to 19.8%.
H1 FY26 PAT witnessed a massive 98.1% YoY growth to INR 1,937 million, reflecting strong operating leverage.
India operations achieved 15% same-store sales growth and 24.7% H1 revenue growth with a 19.5% EBITDA margin.
Conducted 9.3 million eye tests in H1 FY26 (up 52% YoY), with 46% being first-time users, driving market creation.
International business grew 26.1% in H1 with an 18.2% EBITDA margin, led by performance in Singapore and UAE.
💼 Action for Investors
Investors should monitor the company's successful transition from growth-at-all-costs to high-margin compounding, as evidenced by the 1,150 bps EBITDA margin expansion over three years. The strong same-store sales growth and rapid store densification suggest significant remaining runway in the Indian eyewear market.